Company profile
Biomerica, Inc.
NASDAQ: BMRA · Healthcare · Medical - Devices
#702 of 1,422 Healthcare companies by revenue38th-percentile growth
EA Score
——FH —DQ 54GM —SS 64
v0.1 · 25/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ 3-yr revenue growth, filing timeliness
Methodology →Revenue TTM
$4.3M
Rev growth YoY (TTM)
-23.8%
Net income (FY)
-$5.0M
Employees
54
as of 2026-08-23
Market cap
$5.0M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$5.3M$5.3M2025
Net income-$5.0M-$5.0M2025
Operating income-$5.1M-$5.1M2025
Total assets$5.9M$5.9M2025
Liabilities$1.8M$1.8M2025
Equity$4.1M$4.1M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Biomerica, Inc.’s revenue?
Biomerica, Inc. booked $5.3M in FY2025 revenue, contracting 1.9% year over year — slower than 62% of Healthcare companies we track, at a -93.6% net margin.
Peers · Healthcare
Tristar Wellness Solutions Inc.——WellQuest Medical & Wellness Corporation——Wildflower Brands Inc.——Targeted Medical Pharma, Inc.——Plus Therapeutics, Inc.30DPlus Therapeutics, Inc.38DNeighbors
Orange →Key facts
CEOZackary S. Irani
SectorHealthcare
IndustryMedical - Devices
HeadquartersIrvine, CA
ExchangeNASDAQ: BMRA
Employees54
IPO date1984-09-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.